NeuroOne Medical Technologies Corp announced its financial results for the fiscal year ending September 30, 2024, reporting stockholders equity of at least $2.5 million after a $3.0 million payment related to a distribution agreement.
AI Assistant
NEUROONE MEDICAL TECHNOLOGIES CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.